Pharmaceutical Sciences

Scope & Guideline

Exploring innovative solutions in pharmaceutical sciences.

Introduction

Explore the comprehensive scope of Pharmaceutical Sciences through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore Pharmaceutical Sciences in depth and align your research initiatives with current academic trends.
LanguageMulti-Language
ISSN1735-403x
PublisherTABRIZ UNIV MEDICAL SCIENCES, FAC PHARMACY
Support Open AccessYes
CountryIran
TypeJournal
Convergefrom 2009 to 2024
AbbreviationPHARM SCI-IRAN / Pharm. Sci.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressPO BOX 14766-51664, TABRIZ 14766-51664, IRAN

Aims and Scopes

The journal 'Pharmaceutical Sciences' is dedicated to advancing the field of pharmaceutical research through a multifaceted approach that encompasses various aspects of drug development, delivery systems, and therapeutic interventions. It aims to bridge the gap between laboratory research and clinical applications, providing insights into both innovative methodologies and the practical implications of pharmaceutical practices.
  1. Drug Development and Formulation:
    The journal emphasizes the process of drug discovery and formulation, focusing on novel drug delivery systems, formulation techniques, and the physicochemical properties that affect drug efficacy.
  2. Nanotechnology and Drug Delivery Systems:
    There is a significant focus on the integration of nanotechnology in pharmaceutical sciences, including the design and evaluation of nanoparticles, nanocarriers, and their applications in improving drug bioavailability and targeting.
  3. Clinical Pharmacology and Therapeutics:
    Research on the clinical efficacy and safety of drugs, including randomized controlled trials and pharmacoeconomic analyses, is a core area, providing evidence-based insights into therapeutic interventions.
  4. Biopharmaceuticals and Biotechnology:
    The journal explores biopharmaceutical advancements, including monoclonal antibodies, vaccines, and biologics, along with their formulation and delivery challenges.
  5. Natural Products and Herbal Medicine:
    There is a growing interest in the pharmacological evaluation of natural products, herbal formulations, and their potential therapeutic roles, which is reflected in numerous articles addressing their efficacy and mechanisms.
  6. Toxicology and Safety Assessments:
    The journal includes studies on the toxicity and safety of pharmaceutical compounds, including preclinical and clinical evaluations, which are crucial for regulatory approvals.
  7. Pharmacogenomics and Personalized Medicine:
    Research into how genetic variations affect individual responses to drugs, paving the way for personalized therapeutic strategies, is increasingly represented in the journal.
Recent trends in 'Pharmaceutical Sciences' highlight a dynamic landscape of research themes that are gaining traction. These emerging areas reflect contemporary challenges in healthcare and the ongoing quest for innovative solutions in drug development and therapy.
  1. Nanomedicine and Targeted Therapies:
    There is a marked increase in research focused on nanomedicine, including targeted drug delivery systems that enhance therapeutic efficacy while minimizing side effects, indicating a shift towards more precise treatment modalities.
  2. Artificial Intelligence in Drug Discovery:
    The application of artificial intelligence and machine learning in drug discovery processes is rapidly emerging, facilitating faster and more efficient identification of potential drug candidates and optimization of formulations.
  3. Biologics and Biosimilars:
    Research into biologics, including monoclonal antibodies and biosimilars, is on the rise, reflecting the growing importance of these therapies in treating chronic and complex diseases.
  4. Personalized and Precision Medicine:
    There is a growing emphasis on personalized medicine approaches that tailor treatments based on individual genetic profiles, leading to improved patient outcomes and reduced adverse effects.
  5. Sustainable and Green Chemistry:
    The incorporation of green chemistry principles in pharmaceutical development is becoming increasingly relevant, as researchers seek to minimize environmental impacts and enhance the sustainability of pharmaceutical processes.
  6. Pharmacogenomics and Tailored Therapies:
    Research exploring the intersection of pharmacogenomics and tailored therapeutic strategies is gaining momentum, highlighting the importance of genetic factors in drug metabolism and efficacy.

Declining or Waning

While 'Pharmaceutical Sciences' continues to evolve, certain themes that once held prominence are now appearing less frequently in recent publications. This decline may reflect shifts in research focus, funding priorities, or advancements in technology that render previous approaches less relevant.
  1. Traditional Pharmaceutical Chemistry:
    The emphasis on classical synthetic organic chemistry methods has waned, with a noticeable decrease in publications focused solely on traditional chemical synthesis without the integration of modern techniques such as computer-aided drug design or nanotechnology.
  2. Invasive Clinical Trials:
    There has been a shift away from invasive clinical trials in favor of non-invasive methods and observational studies, reflecting a broader trend towards patient safety and ethical considerations in clinical research.
  3. Conventional Drug Formulations:
    Research on conventional drug formulations, particularly those lacking innovative delivery methods, is declining as the field moves towards more sophisticated, targeted, and personalized drug delivery systems.
  4. Single-Target Drug Approaches:
    The focus on single-target drug discovery is decreasing, with a growing preference for polypharmacology and combination therapies that target multiple pathways for more effective treatment outcomes.

Similar Journals

JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES

Bridging the gap between research and real-world application.
Publisher: FRONTIERS MEDIA SAISSN: Frequency: 1 issue/year

Welcome to the JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES, a prestigious open access journal published by FRONTIERS MEDIA SA since 2008, dedicated to advancing research in the fields of pharmacy and pharmaceutical sciences. With its strong rooting in Canada, this journal has established itself within the academic community by consistently delivering high-quality studies and insights, as evidenced by its respectable Q2 ranking in both Medicine (miscellaneous) and Pharmaceutical Science categories for 2023, along with a notable 77th percentile ranking in Pharmaceutical Science on Scopus. Spanning over two decades of publication from 1998 to 2024, the journal focuses on critical research areas including pharmacology, toxicology, and drug development. By providing open access to its articles, the journal ensures that vital scientific information is readily available to researchers, professionals, and students alike, fostering collaboration and innovation within these essential disciplines. We invite you to explore the latest findings and contribute to the ongoing dialogue in pharmaceutical research through this essential platform.

European Journal of Pharmacology

Delivering cutting-edge findings from the forefront of drug research.
Publisher: ELSEVIERISSN: 0014-2999Frequency: 24 issues/year

The European Journal of Pharmacology, a prestigious publication by Elsevier, serves as a vital resource in the field of pharmacology, offering rich insights into drug development and therapeutic applications. Since its inception in 1967, this journal has evolved to encompass groundbreaking research, including pharmacokinetics, toxicology, and innovative pharmacological methodologies, making it an essential platform for researchers and professionals alike. With an impressive impact factor that places it in the Q1 category of pharmacological journals and a Scopus ranking of #49 out of 313, the journal is recognized in the 84th percentile within its category, solidifying its significance in the academic community. Although the journal is not open access, it continues to attract contributions from leading scientists worldwide, ensuring that cutting-edge findings are disseminated effectively. The European Journal of Pharmacology not only highlights advancements in drug discovery and clinical applications but also promotes interdisciplinary collaboration, ultimately contributing to the progress of healthcare globally.

DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY

Unveiling Breakthroughs in Pharmaceutical Science
Publisher: TAYLOR & FRANCIS LTDISSN: 0363-9045Frequency: 12 issues/year

Drug Development and Industrial Pharmacy is a prestigious journal published by Taylor & Francis Ltd, focusing on the critical field of pharmaceutical sciences. With an ISSN of 0363-9045 and an E-ISSN of 1520-5762, the journal has been an essential resource for researchers and professionals since its inception in 1974. It occupies a crucial niche within Drug Discovery, Organic Chemistry, and Pharmaceutical Science, currently ranked in the second and third quartiles, reflecting its solid contribution to the field. The journal encompasses a wide array of topics, including drug development processes, formulation, and industrial manufacturing alongside cutting-edge research in pharmacology and toxicology. With a commendable Scopus ranking demonstrating high relevance—ranked #44 in Pharmaceutical Science—it serves as a vital forum for academia and industry to share innovative findings and methodologies. While it does not offer open access, the journal remains an invaluable resource for those seeking to advance their knowledge and enhance their research in pharmaceutical development.

Istanbul Journal of Pharmacy

Shaping the future of pharmacy through cutting-edge research.
Publisher: ISTANBUL UNIV, FAC PHARMACYISSN: Frequency: 3 issues/year

Istanbul Journal of Pharmacy, published by Istanbul University, Faculty of Pharmacy, is a pivotal platform dedicated to the advancement of pharmaceutical sciences and technology. This journal serves as a vital resource for researchers, professionals, and students alike, seeking to disseminate cutting-edge research, reviews, and innovative methodologies within the pharmaceutical discipline. With a commitment to open access, the journal aims to foster a collaborative environment that promotes information sharing and scholarly discourse. The Istanbul Journal of Pharmacy invites submissions that delve into diverse topics ranging from drug formulation to pharmacokinetics, ensuring that readers are equipped with the latest insights and discoveries in the field. This journal is positioned to enhance scientific communication within the pharmaceutical community and support the continuous evolution of pharmacy practice and education globally.

Advances in Pharmacology and Pharmacy

Advancing the Frontiers of Pharmacological Research
Publisher: HORIZON RESEARCH PUBLISHINGISSN: 2332-0036Frequency: 3 issues/year

Advances in Pharmacology and Pharmacy is a pioneering journal devoted to the dissemination of cutting-edge research in the fields of pharmacology and pharmaceutical sciences. Published by Horizon Research Publishing, this peer-reviewed journal boasts a commitment to advancing knowledge and innovation, making it an essential resource for researchers, industry professionals, and students alike. With an ISSN of 2332-0036 and an E-ISSN of 2332-0044, it provides a platform for high-quality research articles that explore new therapeutic approaches, drug development strategies, and the regulatory aspects of pharmaceutical science. Although currently lacking a formal impact factor, the journal's emphasis on open access ensures that articles are widely available, promoting the sharing of valuable insights and collaborative efforts in the scientific community. Located at 506 N Garfield Ave, Ste 210, Alhambra, CA 91801, the journal welcomes contributions from diverse areas within pharmacology and pharmacy, reinforcing its significance as a vital resource in the ever-evolving landscape of pharmaceutical research.

CURRENT PHARMACEUTICAL BIOTECHNOLOGY

Fostering Collaboration in Cutting-Edge Biotechnology
Publisher: BENTHAM SCIENCE PUBL LTDISSN: 1389-2010Frequency: 15 issues/year

CURRENT PHARMACEUTICAL BIOTECHNOLOGY is a prestigious academic journal dedicated to advancing the field of pharmaceutical biotechnology by publishing high-quality research articles, reviews, and innovatory methodologies. Published by Bentham Science Publishers Ltd, this journal has established a strong reputation in its field, reflected in its 2023 Scopus rankings: it holds an impressive Q2 classification in Pharmaceutical Science and Q3 in Biotechnology, indicating its significant impact within these disciplines. With an ISSN of 1389-2010 and an E-ISSN of 1873-4316, CURRENT PHARMACEUTICAL BIOTECHNOLOGY provides a reliable platform for disseminating valuable research findings and fostering collaboration among researchers, professionals, and students alike. The journal covers a wide array of topics, from drug development and delivery systems to innovative biotechnological techniques, thus serving as an essential resource for anyone interested in the cross-section of pharmaceutical science and biotechnology. Researchers can access a diverse range of articles that explore both theoretical frameworks and practical applications, reflecting the ongoing evolution and challenges in this dynamic field.

YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN

Advancing pharmaceutical knowledge, one article at a time.
Publisher: PHARMACEUTICAL SOC JAPANISSN: 0031-6903Frequency: 12 issues/year

YAKUGAKU ZASSHI - JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, published by the Pharmaceutical Society of Japan, is a key academic journal dedicated to advancing the field of pharmaceutical sciences. Established in 1961 and set to contribute until 2024, this journal publishes original research articles, reviews, and clinical studies that encompass a wide spectrum of topics within pharmacology, toxicology, and pharmaceutics. Although the journal operates under a traditional subscription model, it maintains a recognized reputation with an impact factor that is steadily aligned within its category quartiles—ranking Q3 in Pharmaceutical Science and Q4 in Pharmacology as of 2023. With Scopus rankings reflecting its competitive standing, YAKUGAKU ZASSHI serves as a vital resource for researchers, professionals, and students looking to engage with innovative findings and broaden their understanding of pharmaceutical methodologies and research practices. With a current focus on bridging scientific research with real-world applications, it seeks to foster collaboration and knowledge sharing within the pharmaceutical community.

Turkish Journal of Pharmaceutical Sciences

Pioneering Insights in Drug Development and Therapeutics
Publisher: GALENOS PUBL HOUSEISSN: 1304-530XFrequency: 6 issues/year

The Turkish Journal of Pharmaceutical Sciences, an esteemed publication by GALENOS PUBL HOUSE, has been a prominent platform for research and innovation in the fields of Pharmaceutical Sciences and Molecular Medicine since its inception as an Open Access journal in 2004. Based in Turkey, this journal serves as a vital resource for researchers, professionals, and students keen on exploring the latest advancements in drug development, pharmacology, and therapeutic innovations. With an ISSN of 1304-530X and an E-ISSN of 2148-6247, the journal is indexed in leading databases and has demonstrated strong rankings in the Scopus index, notably securing the second quartile in Pharmaceutical Sciences. Furthermore, it fosters academic collaboration and knowledge dissemination by making its content freely accessible. The journal aims to inspire groundbreaking research, providing an important academic forum for the dissemination of valuable insights that impact the pharmaceutical sector and contribute to global health.

Pharmaceutics

Unlocking the potential of pharmaceuticals through open access.
Publisher: MDPIISSN: Frequency: 12 issues/year

Pharmaceutics is a prestigious journal published by MDPI, specializing in the field of pharmaceutical sciences. With its Open Access model established in 2010, it promotes the dissemination of cutting-edge research, catering to a global audience of researchers, professionals, and students alike. Based in Switzerland, the journal has rapidly gained recognition, currently holding an impressive Q1 ranking in the pharmaceutical science category for 2023 and achieving a Scopus ranking of #32 out of 183 in the domain of Pharmacology, Toxicology, and Pharmaceutics, placing it in the 82nd percentile. The journal's objectives include advancing knowledge in drug formulation, delivery systems, and therapeutic applications, ensuring that published works contribute significantly to both academic discourse and practical applications in the pharmaceutical industry. As part of its commitment to excellence, Pharmaceutics welcomes high-quality manuscripts that inspire innovation and foster collaboration in this vital field.

CURRENT PHARMACEUTICAL DESIGN

Advancing Pharmaceutical Science for a Healthier Future
Publisher: BENTHAM SCIENCE PUBL LTDISSN: 1381-6128Frequency: 46 issues/year

CURRENT PHARMACEUTICAL DESIGN is a leading journal in the fields of Drug Discovery and Pharmacology, published by Bentham Science Publishers Ltd in the dynamic United Arab Emirates. With an impressive historical span from 1995 to 2024, this journal serves as a vital platform for disseminating innovative research findings, breakthrough methodologies, and critical reviews that shape the future of pharmaceutical sciences. Ranked Q2 in both Drug Discovery and Pharmacology categories according to the 2023 metrics, it places itself within the top-tier percentile, catering to a diverse audience of researchers, industry professionals, and students. The journal’s commitment to high-quality research exploration is evidenced by its Scopus ranking, where it is positioned favorably within its category ranks. Although currently not Open Access, CURRENT PHARMACEUTICAL DESIGN remains an essential resource for those looking to stay at the forefront of pharmacological advancements and drug development strategies.